Prof. Roser Torra runs the Inherited Kidney Diseases Clinic at Fundació Puigvert, Barcelona, Spain. Roser started her work in inherited kidney disorders in 1994 and completed her PhD in molecular genetics of polycystic kidney disease in 1997 at the University of Barcelona. Since then she has been involved in clinical practice and research into genetic renal diseases including ADPKD, Fabry disease, Alport syndrome, ARPKD, TSC, ADTKD, and FSGS. She has published over 150 national and international publications about hereditary kidney diseases. She currently participates in multiple inherited kidney disorders trials, supervises doctoral theses on inherited kidney disease and is an experienced reviewer for several journals, meetings, and project evaluating agencies. Roser also coordinates several working groups and teams, including the Hereditary Kidney Disease Working Group of the Spanish Society of Nephrology and the workpackage on inherited kidney diseases from the Spanish Renal research network (REDINREN). She is also Chairman of the Scientific Committee of the Association for Information and Research on Genetic Kidney Diseases (AIRG-E).
Dr. Benjamin Laskin is an attending physician at Children's Hospital of Philadelphia and an Assistant Professor of Pediatrics at the Perelman School of Medicine at the University of Pennsylvania. Dr. Laskin completed his undergraduate at Duke University where he graduated magna cum laude with a major in Economics and minors in Chemistry and History. He attended the University of Maryland School of Medicine where he graduated summa cum laude. He completed his pediatrics residency and fellowship in pediatric nephrology at Cincinnati Children’s Hospital Medical Center. Following his fellowship, he joined the faculty at Children's Hospital of Philadelphia. Dr. Laskin’s research interests are in infections and kidney disease in immunosuppressed children, including those receiving a bone marrow or solid organ transplant. He is the recipient of a K23 Career Development Award from the National Institutes of Health and a New Investigator Award from the American Society for Blood and Marrow Transplantation. Dr. Laskin has published over 70 manuscripts and several book chapters.